Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/14/2010WO2010115278A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010WO2010115238A1 Method for treating immune disorders
10/14/2010WO2010115230A1 Immunogenic composition and uses thereof
10/14/2010WO2010115229A1 Immunogenic composition and uses thereof
10/14/2010WO2010089671A3 Contiguous overlapping peptides for treatment of birch pollen allergy
10/14/2010WO2010078580A3 Immunotherapy for contact dermatitis using co-signal regulation
10/14/2010WO2010074541A3 Drug delivery carrier using zz domain
10/14/2010WO2010068705A3 Encapsulated agent guided imaging and therapies
10/14/2010WO2010065962A3 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
10/14/2010WO2010065613A3 Annexina2 as immunological target
10/14/2010WO2009109952A3 Detection and treatment of an invasive cancer phenotype
10/14/2010WO2009017833A8 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
10/14/2010US20100263061 Properdin Modulation of Alternative Pathway and Uses Thereof
10/14/2010US20100262115 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100260853 Compositions for pulmonary delivery
10/14/2010US20100260831 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260821 Allergen Desensitization Method
10/14/2010US20100260816 Induction of immunological tolerance
10/14/2010US20100260808 Method for Increasing Immunoreactivity
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260806 Nucleic acids
10/14/2010US20100260805 Peptide for vaccine
10/14/2010US20100260804 Attenuated Uracil Auxotroph of an Apicomplexan and Use Thereof
10/14/2010US20100260803 Bordetella Parapertussis Whole-Cell Vaccine Composition
10/14/2010US20100260802 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/14/2010US20100260801 Polysaccharide vaccine for staphylococcal infections
10/14/2010US20100260800 AVV Vectors and Methods
10/14/2010US20100260799 SIMIAN SUBFAMILY C ADENOVIRUSES SAdV-40, -31, AND -34 AND USES THEREOF
10/14/2010US20100260798 Method for purifying the rabies virus
10/14/2010US20100260797 Influenza composition
10/14/2010US20100260796 Stabilizers for freeze-dried vaccines
10/14/2010US20100260795 Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
10/14/2010US20100260794 Live attenuated salmonella vaccine
10/14/2010US20100260793 Defensin-antigen fusion proteins
10/14/2010US20100260792 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
10/14/2010US20100260791 Chlamydia antigens
10/14/2010US20100260790 S. Pneumoniae Antigens
10/14/2010US20100260789 Products specific to pathogenic strains and their use as vaccines and in immunotherapy
10/14/2010US20100260788 Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties
10/14/2010US20100260787 Human sperm fibrous sheath (FS) proteins: new target antigens for use in therapeutic cancer vaccines and diagnostic screening and Methods of Using Same
10/14/2010US20100260786 Methods of treating drug-resistant cancers
10/14/2010US20100260785 SARP-1 Fusion Proteins and Uses Thereof
10/14/2010US20100260784 Pai-1 binding modulators for the treatment of ocular disorders
10/14/2010US20100260783 Antibody Specific Binding to A Beta Oligomer and the Use
10/14/2010US20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260780 Uniform field magnetization and targeting of therapeutic formulations
10/14/2010US20100260779 Methods and molecules for modulating an immune response
10/14/2010US20100260778 Small-molecule botulinum toxin inhibitors
10/14/2010US20100260777 Treatment and/or prevention of sepsis using an enteral composition
10/14/2010US20100260776 Therapeutic method for reducing angiogenesis
10/14/2010US20100260775 Treatment Of Interstitial Cystitis
10/14/2010US20100260774 Netrin-1 Compositions and Methods of Use Thereof
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
10/14/2010US20100260772 Methods for treating or preventing diseases associated with low bone mass
10/14/2010US20100260771 Method for Diagnosing the Metabolic Syndrome (MS)
10/14/2010US20100260770 Il-33 in inflammatory disease
10/14/2010US20100260769 Endosialin binding molecules
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260767 Composition and Method for Treating Inflammatory Disorders
10/14/2010US20100260766 Stable antibody formulations
10/14/2010US20100260765 Targeted binding agents directed to kdr and uses thereof - 035
10/14/2010US20100260764 Compositions and methods for inhibiting squamous cell carcinoma
10/14/2010US20100260763 Polypeptides, antibody variable domains and antagonists methods for
10/14/2010US20100260762 De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
10/14/2010US20100260761 Antibodies specifically reactive with a tumor necrosis factor related ligand
10/14/2010US20100260760 Human anti-vegf polyclonal antibodies and uses thereof
10/14/2010US20100260759 Immunosuppressive polypeptides and nucleic acids
10/14/2010US20100260758 In vivo modulation of neuronal transport
10/14/2010US20100260757 USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
10/14/2010US20100260756 Antibodies and related molecules that bind to 161p2f10b proteins
10/14/2010US20100260755 Ibudilast and immunomodulators combination
10/14/2010US20100260754 Dkk-1 antibodies
10/14/2010US20100260753 Aminoflavone (nsc 686288) and combinations thereof for treating breast cancer
10/14/2010US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria
10/14/2010US20100260751 Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260749 Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
10/14/2010US20100260748 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
10/14/2010US20100260747 Use of Tetrahydrobiopterin as a Marker and a Therapeutic Agent for Fabry Disease
10/14/2010US20100260746 Novel Bank1 Splice Variant
10/14/2010US20100260745 Methods of using and constructing nanosensor platforms
10/14/2010US20100260744 Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor
10/14/2010US20100260743 Solubilization and Targeted Delivery of Drugs With Self-Assembling Amphiphilic Polymers
10/14/2010US20100260742 Medicament and a method for regulation of the vascular tone
10/14/2010US20100260719 Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
10/14/2010US20100260716 Compounds for treating demyelination conditions
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260712 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection
10/14/2010US20100260711 3-aminosulfonyl substituted indole derivatives and methods of use thereof
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260705 Products for altering il-33 activity and methods thereof
10/14/2010US20100260680 Novel bone mass increasing agent
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010US20100260676 Precision-guided nanoparticle systems for drug delivery
10/14/2010US20100260675 Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 1823